H.R. 4752 (119th)

Reducing Hereditary Cancer Act

referredUnited States· United States Congress· EN

Introduced

23 July 2025

Last action

23 July 2025 · Introduced

Status

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Schrier, Kim [D-WA-8], Rep. Buchanan, Vern [R-FL-16], Rep. Cohen, Steve [D-TN-9], Rep. Dingell, Debbie [D-MI-6], Rep. Gottheimer, Josh [D-NJ-5], Rep. Simon, Lateefah [D-CA-12], Rep. Carson, André [D-IN-7], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Bonamici, Suzanne [D-OR-1], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. Nunn, Zachary [R-IA-3], Rep. McBride, Sarah [D-DE-At Large], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Kennedy, Timothy M. [D-NY-26], Rep. Tonko, Paul [D-NY-20], Rep. Goldman, Daniel S. [D-NY-10], Rep. Bacon, Don [R-NE-2], Rep. Matsui, Doris O. [D-CA-7], Rep. Dean, Madeleine [D-PA-4], Rep. Hayes, Jahana [D-CT-5], Rep. Kiggans, Jennifer A. [R-VA-2], Rep. Owens, Burgess [R-UT-4], Rep. Scholten, Hillary J. [D-MI-3], Rep. Jackson, Jonathan L. [D-IL-1], Rep. Figures, Shomari [D-AL-2], Rep. Grijalva, Adelita S. [D-AZ-7], Rep. Langworthy, Nicholas A. [R-NY-23], Rep. Wilson, Frederica S. [D-FL-24], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Pocan, Mark [D-WI-2]

Subjects

Healthcare

Source updated

18 July 2026

Healthcare

Official source Download file View documents Share

Summary

Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

23 July 2025
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
23 July 2025
Introduced
Introduced in House
Source: IntroReferral
23 July 2025
Introduced
Introduced in House
Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

Introduced in House

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House
Introduced in House · EN · 23 July 2025
View Download Open at official source
Introduced in House
summary · EN · 23 July 2025
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to ← Reducing Hereditary Cancer Act of 2025

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/119th-congress/house-bill/4752
Open data entity: https://api.congress.gov/v3/bill/119/hr/4752
us · 119-hr-4752 · source updated 18 July 2026